• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL CANADA, INC. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL CANADA, INC. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A-IDE
Device Problem Gradient Increase (1270)
Patient Problems Corneal Pannus (1447); Calcium Deposits/Calcification (1758); Stenosis (2263); Complete Heart Block (2627); Cusp Tear (2656)
Event Date 09/24/2014
Event Type  Injury  
Event Description
Echocardiograms revealed elevated gradients and stenosis caused by calcification.Re-do aortic valve replacement and tricuspid valve repair was performed.During the explant procedure, stenosis and calcification were observed on the valve.A 23 mm pericardial valve from another manufacturer was implanted.A permanent pacemaker was implanted on (b)(6) 2014 due to complete heart block.The hospital's pathology report noted calcification, moderate pannus, an area consistent with a tear, and one cusp with limited mobility.It was reported the patient was discharged from the hospital.
 
Manufacturer Narrative
(b)(4).The results of this investigation concluded fibrous thickening of all cusps, nodular calcifications within the tissue of each cusp, fibrous pannus ingrowth on the outflow surface of cusps 2 and 3, and a tear in cusp 1.Special stains were negative for organisms, and no acute inflammation was present.There was no evidence found to suggest the cause of the fibrous thickening, pannus formation, calcification formation, and cuspal tear were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the fibrous thickening, pannus formation, calcification formation, and cuspal tear remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6L7
CA  J2S 6L7
Manufacturer (Section G)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6L7
CA   J2S 6L7
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key4213469
MDR Text Key5153299
Report Number8020430-2014-00011
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/01/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2009
Device Model NumberTF-23A-IDE
Device Catalogue NumberTF-23A-IDE
Device Lot Number0002684687
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/04/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/01/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/06/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
Patient Weight78
-
-